KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Oct 24, 2025 >>  ABB India 5182.05  [ -0.07% ]  ACC 1849.85  [ -0.35% ]  Ambuja Cements 555.45  [ -1.60% ]  Asian Paints Ltd. 2503.05  [ 0.05% ]  Axis Bank Ltd. 1242.05  [ -1.38% ]  Bajaj Auto 9083  [ 0.47% ]  Bank of Baroda 266.35  [ -0.15% ]  Bharti Airtel 2029.1  [ 1.03% ]  Bharat Heavy Ele 231.25  [ -1.26% ]  Bharat Petroleum 330.05  [ -0.33% ]  Britannia Ind. 6050  [ -0.25% ]  Cipla 1583.75  [ -3.74% ]  Coal India 394.1  [ 0.41% ]  Colgate Palm 2237.85  [ -2.23% ]  Dabur India 508.45  [ -0.52% ]  DLF Ltd. 773.25  [ -0.11% ]  Dr. Reddy's Labs 1284  [ 0.32% ]  GAIL (India) 181.1  [ 0.64% ]  Grasim Inds. 2838.4  [ -0.89% ]  HCL Technologies 1523.65  [ -0.03% ]  HDFC Bank 994.7  [ -1.41% ]  Hero MotoCorp 5538.05  [ -0.87% ]  Hindustan Unilever L 2517.4  [ -3.20% ]  Hindalco Indus. 824.15  [ 3.99% ]  ICICI Bank 1375.45  [ 0.88% ]  Indian Hotels Co 736.2  [ -0.16% ]  IndusInd Bank 755.4  [ -0.62% ]  Infosys L 1525.4  [ -0.23% ]  ITC Ltd. 417.1  [ 0.30% ]  Jindal Steel 1007.6  [ -0.14% ]  Kotak Mahindra Bank 2186.85  [ -1.72% ]  L&T 3904.35  [ -0.35% ]  Lupin Ltd. 1931.4  [ -0.45% ]  Mahi. & Mahi 3624.8  [ 0.06% ]  Maruti Suzuki India 16263.35  [ -0.73% ]  MTNL 42  [ -0.28% ]  Nestle India 1281.4  [ 0.62% ]  NIIT Ltd. 106.85  [ -1.25% ]  NMDC Ltd. 74.21  [ 0.03% ]  NTPC 339.45  [ -0.92% ]  ONGC 254.85  [ 0.97% ]  Punj. NationlBak 116.9  [ -1.02% ]  Power Grid Corpo 288.55  [ -0.38% ]  Reliance Inds. 1451.45  [ 0.23% ]  SBI 904.4  [ -0.77% ]  Vedanta 495.7  [ 2.66% ]  Shipping Corpn. 274.15  [ 9.57% ]  Sun Pharma. 1699.6  [ 0.63% ]  Tata Chemicals 900.35  [ -0.45% ]  Tata Consumer Produc 1154.5  [ -0.65% ]  Tata Motors Passenge 403.5  [ -0.58% ]  Tata Steel 174.5  [ 0.23% ]  Tata Power Co. 397.4  [ -0.03% ]  Tata Consultancy 3062.45  [ -0.40% ]  Tech Mahindra 1453.15  [ -0.66% ]  UltraTech Cement 11911.4  [ -1.91% ]  United Spirits 1356.45  [ 0.42% ]  Wipro 242.95  [ -0.59% ]  Zee Entertainment En 104.8  [ -0.90% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

MEDICAMEN BIOTECH LTD.

24 October 2025 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE646B01010 BSE Code / NSE Code 531146 / MEDICAMEQ Book Value (Rs.) 159.80 Face Value 10.00
Bookclosure 19/09/2025 52Week High 630 EPS 5.24 P/E 67.48
Market Cap. 479.64 Cr. 52Week Low 293 P/BV / Div Yield (%) 2.21 / 0.28 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
MBL was incorporated as a public limited company under the Companies Act, 1956, on December 22, 1993. The certificate of commencement of business was obtained on January 31, 1994. The company has jointly been promoted by Mr.V.Kumar, Mr.Bal Kishan Gupta, Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh.

MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst, Cadila, Hindustan Ciba, Purepharma, Oboi Labs etc. and exporting to countries like Germany, Russia, Holland, CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales.

MBL has obtained permission for production of tablets, capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited, New Delhi and Pure Pharma Private Limited, Indore respectively.

2010

-The Company has recommended a final dividend of Rs. 0.75 per equity share (being 7.5% on the face value of Rs. 10 per share)

-The Company appointed Mr. B.K.Gupta as Managing Director.

2011

-The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan.

2013

-Ms. Harshita Sharma has been appointed as Additional Director of the company.

2016 -Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd.

2019 -FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant.

2020 -Global API Facility started Dahej API Plant.

2021 -Operations started Haridwar formulation Unit II(FDF).

2023 --Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.

2024 -Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece. -Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.